DRAM Surged Month While Chips Rally, Memory ETFs Diverge
A sudden burst in DRAM-focused ETFs outpaced the broader semiconductor market this month, but market watchers warn a ...
Analyze which crypto assets deliver real project utility, looking at use cases, partnerships, and on-chain activity to gauge authenticity.
28,337 articlesA sudden burst in DRAM-focused ETFs outpaced the broader semiconductor market this month, but market watchers warn a ...
A veteran SpaceX backer contends the $2 trillion IPO valuation understates the long-term growth in space infrastructu...
Air France will suspend flights to Havana for several weeks as Cuba faces a worsening fuel shortage and a weakened ec...
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
A small regional insurer with a long dividend track record is drawing attention for its roughly 4.4% yield as retiree...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
The market presses higher as investors cling to earnings resilience and policy stability, with AI and defense leading...
When tech led a market drop, McDonald’s showed strength. This article breaks down why mcdonald's popped while nasdaq ...
IonQ posted triple-digit revenue growth for 2025, reaching a new high, while losses intensified. The stock has fallen...
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Private AI leaders OpenAI and Anthropic see valuations near $1 trillion as investors chase growth. A cooling IPO wind...
The NANC ETF, built to mirror congressional disclosure trades, is facing a tougher 2026 as interest rates move higher...